Inhalon Biopharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 17

Inhalon Biopharma General Information

Description

Developer of an inhaled immunotherapy designed to treat a variety of acute respiratory infections. The company's platform seeks to harness the power of biologics designed for mucosal applications in treating and preventing respiratory infections, enabling doctors to trace the pathogens in mucus secretions for treating diseases of the respiratory tract.

Contact Information

Website
www.inhalon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5151 McCrimmon Parkway
  • Suite 220
  • Morrisville, NC 27560
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5151 McCrimmon Parkway
  • Suite 220
  • Morrisville, NC 27560
  • United States
+1 (919)

Inhalon Biopharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inhalon Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private Completed Clinical Trials - Phase 1
9. Later Stage VC (Series A) 01-Dec-2023 Completed Clinical Trials - Phase 1
8. Grant 01-Jan-2023 Completed Clinical Trials - Phase 1
7. Grant 01-Jan-2023 Completed Clinical Trials - Phase 1
6. Grant 12-Jul-2022 Completed Clinical Trials - Phase 1
5. Grant 01-Jan-2022 Completed Clinical Trials - Phase 1
4. Debt - General 01-Jan-2022 Completed Clinical Trials - Phase 1
3. Seed Round 16-Sep-2020 Completed Pre-Clinical Trials
2. Grant 26-May-2021 $7M Completed Pre-Clinical Trials
1. Grant $4M Completed Pre-Clinical Trials
To view Inhalon Biopharma’s complete valuation and funding history, request access »

Inhalon Biopharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Inhalon Biopharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Inhalon Biopharma Patents

Inhalon Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023275534-A1 Compositions and methods for inhalable therapeutics Pending 23-May-2022
EP-4529467-A2 Compositions and methods for inhalable therapeutics Pending 23-May-2022
EP-4529467-A4 Compositions and methods for inhalable therapeutics Pending 23-May-2022
WO-2023230486-A2 Compositions and methods for inhalable therapeutics Inactive 23-May-2022
WO-2023230486-A3 Compositions and methods for inhalable therapeutics Inactive 23-May-2022 C07K16/104
To view Inhalon Biopharma’s complete patent history, request access »

Inhalon Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inhalon Biopharma Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambrian Growth Partners Growth/Expansion Minority
K2X Venture Capital Minority
Rivermount VC Fund Venture Capital Minority
SCP Ventures Venture Capital Minority
Ulmus Investment Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Inhalon Biopharma FAQs

  • When was Inhalon Biopharma founded?

    Inhalon Biopharma was founded in 2018.

  • Where is Inhalon Biopharma headquartered?

    Inhalon Biopharma is headquartered in Morrisville, NC.

  • What is the size of Inhalon Biopharma?

    Inhalon Biopharma has 9 total employees.

  • What industry is Inhalon Biopharma in?

    Inhalon Biopharma’s primary industry is Drug Discovery.

  • Is Inhalon Biopharma a private or public company?

    Inhalon Biopharma is a Private company.

  • What is Inhalon Biopharma’s current revenue?

    The current revenue for Inhalon Biopharma is .

  • How much funding has Inhalon Biopharma raised over time?

    Inhalon Biopharma has raised $11.1M.

  • Who are Inhalon Biopharma’s investors?

    Cambrian Growth Partners, K2X, Rivermount VC Fund, SCP Ventures, and Ulmus Investment are 5 of 17 investors who have invested in Inhalon Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process